S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
Log in

ResMed Short Interest Ratio and Short Volume

+6.16 (+2.86 %)
(As of 01/25/2021 12:00 AM ET)
Today's Range
Now: $221.68
50-Day Range
MA: $213.20
52-Week Range
Now: $221.68
Volume490,446 shs
Average Volume443,769 shs
Market Capitalization$32.12 billion
P/E Ratio47.57
Dividend Yield0.72%

Short Interest

ResMed (NYSE:RMD) Short Interest Data

Current Short Volume:1,130,000 shares
Previous Short Volume:1,170,000 shares
Change Vs. Previous Month:-3.42%
Dollar Volume Sold Short:$248.94 million
Short Interest Ratio / Days to Cover:2.0
Last Record Date:December, 31 2020
Outstanding Shares:143,390,000 shares
Short Percent of Float:0.00%
Today's Trading Volume:490,446 shares
Average Trading Volume:443,769 shares
Today's Volume Vs. Average:10.52%

ResMed (NYSE:RMD) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
12/31/20201,130,000 $248.94 million -3.4%0.0%2.3$220.30
12/15/20201,130,000 $242.51 million -3.4%0.0%2.3$214.61
11/30/20201,170,000 $255.28 million -20.4%0.0%2.3$218.19
11/15/20201,470,000 $308.11 million 9.7%0.0%2.9$209.60
10/30/20201,340,000 $287.75 million -8.8%0.0%2.4$214.74
10/15/20201,470,000 $271.73 million -3.3%0.0%2.5$184.85
9/30/20201,520,000 $270.04 million 2.7%0.0%2.6$177.66
9/15/20201,480,000 $250.18 million -11.4%0.0%2.4$169.04
8/31/20201,670,000 $288.91 million 3.7%0.0%2.5$173.00
8/14/20201,610,000 $288.05 million -9.0%0.0%2.3$178.91
7/31/20201,770,000 $320.35 million 0.6%0.0%2.6$180.99
7/15/20201,760,000 $356.42 million -18.1%0.0%2.6$202.51
6/30/20202,150,000 $435.25 million 54.7%0.0%3.1$202.44
6/15/20201,390,000 $265.48 million -18.2%0.0%1.9$190.99
5/29/20201,700,000 $309.16 million -11.0%0.0%2$181.86
5/15/20201,910,000 $307.17 million 22.4%0.0%2.2$160.82
4/30/20201,560,000 $239.79 million -14.3%0.0%1.8$153.71
4/15/20201,820,000 $308.09 million 6.4%1.3%2.2$169.28
3/31/20201,710,000 $275.31 million -8.6%1.2%2.1$161.00
3/13/20201,871,400 $299.09 million -16.5%0.0%3.4$159.82
2/28/20202,240,000 $271.85 million -5.5%1.6%4.1$121.36
2/14/20202,370,000 $383.25 million 10.8%1.7%4.7$161.71
1/31/20202,140,000 $355.07 million -1.4%1.5%4.3$165.92
1/15/20202,170,000 $378.34 million -4.0%1.5%4.3$174.35
12/31/20192,260,000 $367.00 million 0.9%1.6%4.6$162.39

ResMed (NYSE:RMD) Short Interest FAQ

speech bubbles
speech bubbles

What is ResMed's current short interest?

Short interest is the volume of ResMed shares that have been sold short but have not yet been covered or closed out. As of December 31st, investors have sold 1,130,000 shares of RMD short. 0.00% of ResMed's shares are currently sold short. View details.

What is a good short interest ratio for ResMed?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ResMed currently has a short interest ratio of 2.0.

Is ResMed's short interest increasing or decreasing?

ResMed saw a drop in short interest in the month of December. As of December 31st, there was short interest totaling 1,130,000 shares, a drop of 3.4% from the previous total of 1,170,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does ResMed's short interest compare to its competitors?

0.00% of ResMed's shares are currently sold short. Here is how the short interest of companies in the sub-industry of "health care equipment" compare to ResMed: Abbott Laboratories (0.00%), Medtronic plc (0.00%), Intuitive Surgical, Inc. (0.00%), Becton, Dickinson and Company (0.00%), Edwards Lifesciences Co. (0.00%), Boston Scientific Co. (0.00%), IDEXX Laboratories, Inc. (0.81%), Baxter International Inc. (1.31%), DexCom, Inc. (0.00%), and Hologic, Inc. (1.87%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.18 billion), ViacomCBS Inc. ($4.71 billion), Analog Devices, Inc. ($4.45 billion), Aon Plc ($4.28 billion), Snap Inc. ($3.70 billion), Moderna, Inc. ($3.00 billion), The Clorox Company ($2.46 billion), Peloton Interactive, Inc. ($2.40 billion), The Kroger Co. ($2.38 billion), and Expedia Group, Inc. ($2.37 billion). View all of the most shorted stocks.

What does it mean to sell short ResMed stock?

Short selling RMD is an investing strategy that aims to generate trading profit from ResMed as its price is falling. ResMed's stock is trading up $6.16 today. To short ResMed stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that ResMed will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ResMed?

A short squeeze for ResMed occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RMD, which in turn drives the price of the stock up even further.

How often is ResMed's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RMD, twice per month. The most recent reporting period available is December, 31 2020.

This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.